Macquarie Group LTD Meridian Bioscience Inc Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $14,893 - $16,171	-482 Closed	0 $15,000
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $4,505 - $6,814	-228 Reduced 32.11%	482 $13,000
Q2 2020 Aug 11, 2020	BUY	$7.84 - $23.29 $5,566 - $16,535	710 New	710 $17,000
Q3 2018 Nov 15, 2018	SELL	$14.85 - $16.35 $111,018 - $122,232	-7,476 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $103,168 - $125,596	7,476 New	7,476 $119,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.